Literature DB >> 10217099

Thrombosis in pregnancy: maternal and fetal issues.

I A Greer1.   

Abstract

Pulmonary thromboembolism is the main cause of maternal death in the UK and current trends show an increase. Deep-vein thrombosis underlies this disorder. Important issues include pathophysiology, diagnosis, and management of thrombosis in pregnancy, especially the use of anticoagulants. Congenital and acquired thrombophilias contribute to the pathophysiological processes that underlie miscarriage, intrauterine growth restriction, and pre-eclampsia, and raises new possibilities for intervention. The high prevalence of thrombophilic defects in the population, the association of defects with maternal and fetal disorders, and special considerations for management make it essential for obstetricians to understand this area.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217099     DOI: 10.1016/S0140-6736(98)10265-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  59 in total

Review 1.  Pregnancy and the lungs.

Authors:  P Bhatia; K Bhatia
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

2.  The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

Authors:  R L Nachman
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

Review 3.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

4.  Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.

Authors:  Masaya Hirose; Fuminori Kimura; Hua-Qin Wang; Koichi Takebayashi; Masashi Kobayashi; Keiko Nakanishi; Minoru Akiyama; Toshio Kimura; Yoichi Noda
Journal:  J Thromb Thrombolysis       Date:  2002-04       Impact factor: 2.300

5.  Practices for predicting and preventing preterm birth in Ireland: a national survey.

Authors:  V Smith; D Devane; S Higgins
Journal:  Ir J Med Sci       Date:  2010-10-17       Impact factor: 1.568

6.  Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial.

Authors:  Ida Martinelli; Piero Ruggenenti; Irene Cetin; Giorgio Pardi; Annalisa Perna; Patrizia Vergani; Barbara Acaia; Fabio Facchinetti; Giovanni Battista La Sala; Maddalena Bozzo; Stefania Rampello; Luca Marozio; Olimpia Diadei; Giulia Gherardi; Sergio Carminati; Giuseppe Remuzzi; Pier Mannuccio Mannucci
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

7.  Family history of venous thromboembolism and identifying factor V Leiden carriers during pregnancy.

Authors:  Amanda L Horton; Valerija Momirova; Donna Dizon-Townson; Katharine Wenstrom; George Wendel; Philip Samuels; Baha Sibai; Catherine Y Spong; Margaret Cotroneo; Yoram Sorokin; Menachem Miodovnik; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner
Journal:  Obstet Gynecol       Date:  2010-03       Impact factor: 7.661

Review 8.  Inherited thrombophilia and pregnancy associated venous thromboembolism.

Authors:  Wendy Lim; John W Eikelboom; Jeffrey S Ginsberg
Journal:  BMJ       Date:  2007-06-23

9.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

10.  Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death.

Authors:  Dean Thumkeo; Jeongsin Keel; Toshimasa Ishizaki; Masaya Hirose; Kimiko Nonomura; Hiroko Oshima; Masanobu Oshima; Makoto M Taketo; Shuh Narumiya
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.